Pravin Dugel

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cincinnati, OH
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Todd Anderman, Attorney-in-Fact for Pravin Dugel
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Pravin Dugel

Form 4 holding Executive Chairman, President and CEO, Director

OCULAR THERAPEUTIX, INC

Security class
Common Stock
Shares / value
694,811
Estimated value
$5,885,049
Report date
16 Jun 2026
Price
$8.47
Ownership
By Pravin Dugel 2024 Irrevocable Trust
Form 4 holding Executive Chairman, President and CEO, Director

OCULAR THERAPEUTIX, INC

Security class
Performance Stock Option (Right to Buy)
Shares / value
2,750,000
Estimated value
Report date
11 Jun 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding President, Director

IVERIC bio, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
Report date
11 Jul 2023
Price
$39.45
Ownership
Direct
Form 4 holding President, Director

IVERIC bio, Inc.

Security class
Restricted Stock Units
Shares / value
0
Estimated value
Report date
11 Jul 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding President, Director

IVERIC bio, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
11 Jul 2023
Price
$10.03
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Pravin Dugel

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .